Mesenchymal stem cell therapies (Stempeutics)

N/A

Report date: 2025/12/08 15:09:52

Base Information

Drug NameMesenchymal stem cell therapies (Stempeutics)
Drug Alias NameEx-vivo cultured adult human mesenchymal stem cellsEx vivo cultured adult allogenic mesenchymal stem cellsEx-vivo cultured adult bone marrow derived allogeneic mesenchymal stem cellsStempeucelStempeucel OA +[13] 
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsIschemiaThromboangiitis ObliteransMyocardial Infarction +[4] 
Global Approved IndicationsIschemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2017/03/01
Country/TerritoryIndiaMalaysia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesStempeutics
China Registration ClassN/A

Develop Information

Active CompaniesStempeuticsCipla Ltd
Inactive CompaniesStempeutics Research Pvt Ltd
Active IndicationsIschemiaOsteoarthritis, Knee
Inactive IndicationsThromboangiitis ObliteransMyocardial Infarction

Other Information

ATC CodeV03AX
Related LinksN/A